Skip to main content
Year archive

Chapters Group AG — 2023 filings

All 22 regulatory filings released by Chapters Group AG (MCE) in 2023, sourced directly from the official regulator.

22 Filings
2023 Period
2023 filings (22)
Filing Released Lang
CHAPTERS Group AG: Marlene Carl, Kauf
Director's Dealing
2023-11-27 German
CHAPTERS Group AG: Marlene Carl, Kauf
Director's Dealing
2023-11-27 German
Raising of Additional Equity to Drive Acceleration of Growth
Share Issue/Capital Change
2023-11-24 English
CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 23, 2023
Capital/Financing Update
2023-11-24 English
CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Capital/Financing Update
2023-11-23 English
Halbjahresabschluss 2023
Interim / Quarterly Report H1 2023
2023-10-09 German
CHAPTERS Group AG: 2023 Interim Report Shows Strong Growth in the First Half of the Year
Report Publication Announcement H1 2023
2023-09-29 English
CHAPTERS Group AG: Management buy-out of the property services group of NGC Nachfolgekapital GmbH
M&A Activity
2023-09-07 English
CHAPTERS Group AG: Management buy-out of the property services group of NGC Nachfolgekapital GmbH
M&A Activity
2023-09-07 English
CHAPTERS Group AG: Jan-Hendrik Mohr, Erhalt von 25.782 Aktien als Performance Fee aus der Beendigung eines Anlageberatungsvertrags
Director's Dealing
2023-08-16 German
CHAPTERS Group AG: MSA Capital GmbH, Erhalt von 25.778 Aktien als Performance Fee aus der Beendigung eines Anlageberatungsvertrags
Director's Dealing
2023-08-15 German
Officially Starting the Next CHAPTER
Regulatory Filings
2023-08-01 English
MEDIQON Group AG: Expansion of Capital Base to Accelerate Growth
Share Issue/Capital Change
2023-05-26 English
MEDIQON Group AG: Privatplatzierung der am 25.05.2023 beschlossenen Barkapitalerhohung aus genehmigtem Kapital erfolgreich abgeschlossen
Share Issue/Capital Change
2023-05-26 German
MEDIQON Group AG: Durchfuhrung einer Barkapitalerhohung aus genehmigtem Kapital und erneute Platzierung der Ewigkeitsanleihe 2020 beschlossen sowie Verpflichtung zum Ruckkauf der Anleihe 2020
Capital/Financing Update
2023-05-26 German
MEDIQON Group AG: 2022 Annual Report - Strong Operating Performance and Continued Success with Acquisitions - Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of Growth
Audit Report / Information FY 2022
2023-05-24 English
Jahresabschluss 2022
Audit Report / Information FY 2022
2023-05-23 German
MEDIQON Group AG: Annual Report for the 2022 financial year published
Report Publication Announcement
2023-05-17 English
MEDIQON Group AG: Jan-Hendrik Mohr, Kauf
Director's Dealing
2023-04-19 German
MEDIQON Group AG: Jan-Hendrik Mohr, Kauf
Director's Dealing
2023-04-17 German
MEDIQON Group AG: Group growth continued again in the 2022 financial year and a successful start to the 2023 financial year
Earnings Release FY 2022
2023-04-14 English
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended
Board/Management Information
2023-02-16 English